Literature DB >> 15790086

"Collateral damage": antibiotics and the risk of Clostridium difficile infection.

Felix K Yam1, Kelly M Smith.   

Abstract

Patients undergoing orthopedic surgery are at increased risk for infection, and antimicrobial use continues to be required. Antimicrobial selection, however, is an important consideration given the increasing incidence and severity of C. difficile infection described in the literature. When choosing antimicrobials for prophylaxis and treatment, evaluate patients for risk factors that may predispose them to C. difficile infection. Patients receiving multiple antibiotics or broad-spectrum antibiotics, women, patients with concurrent proton pump inhibitor use, and those with renal failure are at increased risk. Choice of antibiotics should be evaluated for their potential or likelihood to cause C. difficile infection. When a number of these risk factors are present, avoiding the use of high-risk antibiotics may be warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790086     DOI: 10.3928/0147-7447-20050301-12

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  Clostridium difficile colitis in patients undergoing lower-extremity arthroplasty: rare infection with major impact.

Authors:  Mitchell Gil Maltenfort; Mohammad R Rasouli; Todd A Morrison; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

2.  A Prospective Evaluation of Adverse Reactions to Single-Dose Intravenous Antibiotic Prophylaxis During Outpatient Hand Surgery.

Authors:  Kristin Sandrowski; David Edelman; Michael Rivlin; Christopher Jones; Mark Wang; Gregory Gallant; Pedro K Beredjiklian
Journal:  Hand (N Y)       Date:  2018-07-15

3.  The Burden of Clostridium difficile after Cervical Spine Surgery.

Authors:  Javier Z Guzman; Branko Skovrlj; Edward S Rothenberg; Young Lu; Steven McAnany; Samuel K Cho; Andrew C Hecht; Sheeraz A Qureshi
Journal:  Global Spine J       Date:  2015-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.